Nav: Home

The CONSERVE trial: Noninvasive imaging can guide more selective invasive coronary angiography

August 29, 2016

Rome, Italy 29 August 2016 - In stable symptomatic patients with suspected coronary artery disease, a strategy of using non-invasive computed tomography (CT) to guide the selective use of invasive coronary angiography was safe, and less expensive compared with direct invasive angiography.

Findings of the CONSERVE (Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization) trial, presented in a Hot Line session at ESC Congress 2016, showed the CT-guided strategy was associated with no differences in major adverse cardiovascular events (MACE), and resulted in an 86% reduction in invasive coronary angiography (ICA) compared to the direct invasive angiography approach.

"Our study observed lower rates of invasive procedure, which were also associated with cost savings," commented investigator Hyuk-Jae Chang, MD, PhD from Yonsei University College of Medicine, in Seoul, Republic of Korea.

"The message from this trial is that, if we use coronary CT angiography as a gatekeeper to the catheterization lab in stable symptomatic patients with suspected coronary artery disease, we'll reduce costs with sufficient safety."

The randomized, multicenter, controlled trial included 1,530 patients with indications for invasive angiography, based on current guidelines.

They were randomized to direct versus selective invasive coronary angiography, the latter driven by physician referrals based on initial results of the CT.

For the primary endpoint of 12-month MACE, rates were 5% in both groups, with the secondary endpoint of mean cardiovascular cost per patient being significantly lower in the selective versus direct invasive coronary angiography arm ($2,883 vs $6,031).

There was a >$3000 cost savings per person in this trial over 12 months using medicare costs. If we account for the 4.6M caths that are done (3.6 in the outpatient setting), we can see that math works out to >$10B each year.

In addition to being economically meaningful, the significant reduction in invasive procedures is clinically important, said Prof. Chang "CT guided strategy may uncouple the diagnosis - treatment cascade of ICA which promote excess revascularization and subsequently expose patients to non-negligible risk related to invasive procedure."
-end-
Notes to editors

Sources of funding: The CONSERVE trial was funded by an investigator-initiated unrestricted grant from GE healthcare (Princeton, New Jersey) and Severance Hospital of Yonsei University (Seoul, Korea).

Disclosures: The investigators have no financial conflicts regarding this study.

ESC Press Office

For background information, please contact the ESC Press Office at media@escardio.org.

For press enquiries, please contact, the Media & Press Coordinator, Jacques Olivier Costa: +393427028575

For independent comment on site, please contact the ESC Spokesperson coordinator, Celine Colas: +393402405148

To access all the scientific resources from the sessions during the congress, visit ESC Congress 365.

About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 120 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

About ESC Congress 2016

ESC Congress is the world's largest gathering of cardiovascular professionals contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2016 takes place 27 to 31 August at the Fiera di Roma in Rome, Italy. The scientific programme is here. More information is available from the ESC Press Office at press@escardio.org

This press release accompanies both a presentation and an ESC press conference at the ESC Congress 2016. Edited by the ESC from material supplied by the investigators themselves, this press release does not necessarily reflect the opinion of the European Society of Cardiology. The content of the press release has been approved by the presenter.

European Society of Cardiology

Related Strategy Articles:

Government's counterterrorism strategy is having little impact in the NHS
NHS organizations are obliged by law to report people it fears at risk of becoming terrorists under the Prevent strategy -- part of the UK government's counterterrorism plan aimed at stopping people becoming terrorists.
New strategy produces stronger polymers
MIT researchers have found a way to reduce the number of loops in polymer networks such as gels, plastics, and rubber.
Regardless of income and age, best investment strategy is to diversify
Michael O'Doherty, associate professor of finance in the Trulaske College of Business, developed a model to determine the optimal retirement savings decisions of households with access to both pre-tax and post-tax accounts.
What cancer research can learn from military strategy
When David Gisselsson Nord, a cancer researcher at Lund University in Sweden, read a history book last summer, he was struck by the similarities between how cancer and insurgencies evolve over time.
Game theory could improve cyberwarfare strategy
Whether a nation should retaliate against a cyber attack is a complicated decision, and a new framework guided by game theory could help policymakers determine the best strategy.
New pop-up strategy inspired by cuts, not folds
Origami-inspired materials use folds in materials to embed powerful functionality.
Study points to treatment strategy for anorexia
New research conducted in adolescent rodents provides insights on the mechanisms behind anorexia nervosa and points to a potential treatment strategy.
For decision-makers who want the best, focus on the strategy
People make decisions every day, some trivial, like what to eat for lunch, while others are more significant -- career, marriage, buying a home.
New design strategy for longer lasting batteries
Christopher Wolverton, professor of materials science and engineering in Northwestern's McCormick School of Engineering, has developed a new computational design strategy that can pinpoint optimal materials with which to coat the cathode in lithium-ion batteries, protecting it from degradation and ultimately extending the battery's -- and device's -- life.
Targeting legumain as a novel therapeutic strategy in cancers
This review will be the first to summarize the expression of legumain (LGMN) in common cancers, as well as its roles in tumourigenesis and metastasis.

Related Strategy Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...